These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 21619430)

  • 1. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant cancer biomarkers and pharmacogenetic assays.
    Patel JN; Mandock K; McLeod HL
    J Oncol Pharm Pract; 2014 Feb; 20(1):65-72. PubMed ID: 23353710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
    Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
    Stud Health Technol Inform; 2014; 205():261-5. PubMed ID: 25160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B; Carter A; Kristova V
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder views on pharmacogenomic testing.
    Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
    Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic application in personalized cancer treatment.
    Kristyanto H; Utomo AR
    Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of cancer drugs.
    Hertz DL; Rae J
    Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic biomarkers for personalized medicine.
    Chen JJ; Lin WJ; Chen HC
    Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of genotype-guided cancer therapy in solid tumors.
    Patel JN
    Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
    Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
    Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.
    Elie V; de Beaumais T; Fakhoury M; Jacqz-Aigrain E
    Pharmacogenomics; 2011 Jun; 12(6):827-43. PubMed ID: 21692614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
    Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
    Stud Health Technol Inform; 2014; 198():25-31. PubMed ID: 24825681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.
    Palmirotta R; De Marchis ML; Ludovici G; Ferroni P; Abete P; Guadagni F; Della-Morte D
    Methods Mol Biol; 2014; 1175():45-65. PubMed ID: 25150866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.